Cutting Edge Research in Oculoplastics
My Session Status
Learning Objectives:
At the end of this session participants will be able to:
• Integrate new research techniques and ideas in managing Oculoplastics conditions.
CanMeds Roles: Medical Expert, Collaborator
Sub Sessions
Authors: Kevin Hodgson, André S. Pollmann, Kathryn McFadden, Ahsen Hussain.Author Disclosure Block: K. Hodgson: None. A.S. Pollmann: None. K. McFadden: None. A. Hussain:None.Abstract Body:Purpose: To present the clinical signs, diagnosis, treatment, and follow-up of a patient with a novel presentation of aberrant lacrimal gland ductules.Study Design: Descriptive ...
Authors: David Plemel, Ezekiel Weis, Karim Punja, Michael Ashenhurst, Andrzej Kulaga. Author Disclosure Block: D. Plemel: None. E. Weis: None. K. Punja: Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s); Alcon Canada Inc, Allergan Inc, Clarion Medical Technologies. Membership on advisory boards or speakers’ bureaus; Description of relationship(s); Consultant / Advisor. M. Ashenhurst: None. ...
Authors: Helya Aghazadeh, Audrey Chan. Author Disclosure Block: H. Aghazadeh: None. A. Chan: None.Abstract Body:Purpose: To investigate the role and reliability of apraclonidine (brand name Iopidine) eye drops in assessment of ptosis and surgical planning for ptosis repair.Study Design: This study is designed as a retrospective chart review.Methods: A ret...
Authors: Ryan Eidsness, Malshi Kurunatilake, Mussawar Iqbal. University of Saskatchewan.Author Disclosure Block: R. Eidsness: None. M. Kurunatilake: None. M. Iqbal: NoneAbstract Body:Purpose: Discuss a case of advanced Squamous cell carcinoma (SCC) involving the eyelid, conjunctiva, and orbit that responded to Cemiplimab (Libtayo)Study Design: Study design: Case Study...
Authors: Jobanpreet Dhillon, Nishaant Bhambra, Daniel Q. Li, Sabrina Bergeron, Georges Shenouda, Miguel N. Burnier, Bryan P. Arthurs, Christian El-HadadAuthor Disclosure Block: *to be filled out by COS staff based on disclosure formTitle: Cemiplimab as Immunotherapy for Locally Advanced Squamous Cell Carcinoma of the EyeAbstract Body: Click or tap here to enter text.
Authors: Khaldon Abbas, Stuti M. Tanya, Bonnie He, Edsel Ing.Author Disclosure Block: K. Abbas: None. S.M. Tanya: None. B. He: None. E. Ing: None.Abstract Body:Purpose: The hazard associated with percutaneous sharps injuries (PSI) has encouraged behaviour change and the use of safety-engineered surgical sharps. The purpose of this study was to provide a comprehensive review of PSI and the benef...
Authors: Georges Nassrallah, Ramez Borbara, Blake Murphy, Asim Ali, Navdeep Nijhawan.Author Disclosure Block: G. Nassrallah: None. R. Borbara: None. B. Murphy: None. A. Ali: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Santen. Any direct financial payments including receipt of honoraria; Description of relationship(s); Consultant. Funded grants or clinical trials; Name of for-pro...